Search for: "WATSON PHARMA, INC., AND WATSON LABORATORIES, INC."
Results 61 - 80
of 82
Sort by Relevance
|
Sort by Date
9 May 2010, 9:58 pm
Watson Pharmaceuticals, Inc. et al. 2:10-cv-00647; filed May 5, 2010 in the District Court of Nevada • Plaintiff: Eli Lilly & Company • Defendants: Watson Pharmaceuticals, Inc.; Watson Laboratories, Inc.; Watson Pharma, Inc. [read post]
5 May 2010, 4:46 am
Watson Laboratories, Inc. [read post]
2 May 2010, 9:52 pm
-Florida; Watson Laboratories, Inc.; Watson Pharma, Inc. [read post]
27 Apr 2010, 10:58 pm
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
18 Mar 2010, 2:30 am
Astellas Pharma US, Inc. [read post]
3 Mar 2010, 5:05 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
3 Mar 2010, 5:05 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
28 Feb 2010, 9:47 pm
Bio-Reference Laboratories, Inc. v. [read post]
17 Feb 2010, 8:00 am
Watson Pharmaceuticals Inc., Watson Laboratories Inc. and Watson Pharma Inc. [read post]
18 Dec 2009, 9:59 am
Watson Laboratories, Inc.- Florida, Watson Pharma Inc. and Watson Pharmaceuticals Inc. [read post]
9 Dec 2009, 3:59 pm
Watson Laboratories Inc. - Florida et al (Patent Docs) Surfaxin (Lucinactant) – US: PTO rules on the availability of multiple interim patent extensions (FDA Law Blog) Taxotere (Docetaxel) – Canada: Federal Court refuses to grant Order of Prohibition against Hospira regarding Docetaxel product: Sanofi v Hospira (Pharmacapsules @ Gowlings) Vigamox (Moxifloxacin) – US: Teva appeals verdict finding ANDA to market generic Vigamox infringes patent: Alcon… [read post]
9 Oct 2009, 9:11 am
Watson Pharmaceuticals Inc., Watson Laboratories, Inc. and Watson Pharma Inc. [read post]
8 Oct 2009, 6:05 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
9 Aug 2009, 10:02 pm
The recalled patches are from Lot Number 145287A, have expiration dates of February 2011 and were manufactured by Watson Laboratories, Inc. and distributed by Watson Pharma, Inc. [read post]
16 Aug 2008, 2:43 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Belgium - eBay wins ruling against L’Oreal in dispute over liability for counterfeit goods sold in online auctions: (Managing Intellectual Property), (Counterfeit Chic), (IPKat), (Class 46), (Techdirt), (Ars Technica) US CAFC holds that copying free software without complying with license is copyright infringement: Robert Jacobsen v… [read post]
6 Jun 2008, 6:49 am
: (Spicy IP) Events 9-12 June: (US) Strategies for management of IP – Chicago: (IPR-Helpdesk), 11 June: US PLI ‘Advanced patent licensing 2008: What you need to know before licensing your patent’ – San Francisco: (Patent Docs), 11 June: MARQUES ‘First meeting with Spanish Judges of the Community Trade Mark Courts’ – Alicante: (Class 46), 13-14 June: Centre for European Economic Research conference on ‘The… [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
15 Mar 2008, 7:00 am
India: Gene silencing: (Spicy IP), India: US Patent reform implications for Indian Pharma: (Spicy IP), India: Generic pharmaceutical industry in the spotlight: (International Law Office), India: Supreme Court refuses to stay a Gujarat High Court decision restraining Ranbaxy from airing its controversial ads directed against Paras Pharma's 'Moov' brand: (Spicy IP),India: Patents on ARV drugs could increase costs: (Generic Pharmaceuticals & IP),US: Survey… [read post]
9 Mar 2008, 7:26 pm
Watson Laboratories, Inc. et al. 3:08-cv-00116; filed March 6, 2008 in the District Court of... [read post]
7 Mar 2008, 2:00 am
: (IPBiz), US: Proposals for the approval of generic biologics under consideration: (Pharmacapsules@Gowlings), US: A paradigm shift in obviousness for pharma, biotech: (IP Law360), US: USPTO’s Bruce Kisliuk addresses ACI Pharma/biotech patent claim drafting and prosecution conference: (Patent Docs), US: New bill to provide biotech companies Sarbanes-Oxley relief: (California Biotech Law Blog), US: Biotech and pharma companies spent millions on… [read post]
